美国遗体供肾非顺序分配的结局
该回顾性研究利用2021至2023年器官共享联合网络数据,分析非顺序分配(OOS)与标准分配肾移植的结局。OOS比例从5.4%升至18.4%,OOS与标准分配的移植物丢失风险无显著差异(AHR 0.94,95%CI 0.85-1.05),配对分析结果一致(AHR 1.10,95%CI 0.86-1.41)。高OOS使用中心的受者接受遗体肾移植率更高(AHR 3.07,95%CI 2.90-3.25)。
要点
- OOS与标准分配的短期移植物失败风险无显著差异。
- 高OOS使用中心的受者遗体肾移植率显著更高。
- OOS受者更多为男性、白人、有私人保险及抢先移植。
核心结论
- OOS与标准分配的短期移植物失败无显著差异。
- 高OOS中心遗体肾移植率更高。
研究设计与样本
- 回顾性观察性研究,使用2021至2023年SRTR数据,比较OOS与标准分配的供受者特征,采用多变量Cox模型评估移植物存活,并进行配对供者分析。
主要发现
- OOS年分配率从2021年5.4%升至2023年18.4%。
- 高OOS使用中心从2021至2022年6月的5个(2.2%)增至2023年的37个(17%)。
- 在高OOS中心登记与遗体肾移植率增加相关(AHR 3.07;95%CI 2.90-3.25)。
- OOS受者更可能为男性(66% vs 59%)、白人(38% vs 32%)、有私人保险(29% vs 24%)及抢先移植(18% vs 10%)。
- OOS与标准分配的总体移植物丢失无显著差异(AHR 0.94;95%CI 0.85-1.05),配对分析一致(AHR 1.10;95%CI 0.86-1.41)。
临床怎么用
- 肾内科医生可参考:在高OOS使用中心登记可能提高遗体肾移植机会。
- OOS分配不增加短期移植物失败风险,可考虑接受此类供肾。
局限性
- 需进一步研究理解人口学差异及OOS分配相关因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: We used national data to examine the outcomes of kidney transplant allocated as out of sequence offers to transplant centers in the United States. Short-term kidney graft failure does not differ between kidneys that were allocated as out of sequence offers versus standard allocation. BACKGROUND: Changes in kidney allocation policies and regulations of Organ Procurement Organizations have affected the volume of organ offers and challenged transplant providers. One consequence is increased kidneys allocated out of sequence (OOS). METHODS: Retrospective observational study using Scientific Registry of Transplant Recipient data from 2021 to 2023, we analyzed donor and recipient characteristics for OOS versus standard kidney allocation and multivariable Cox models to evaluate graft survival. We also compared paired donors (one kidney OOS and the other standard allocation). RESULTS: Annual OOS kidney allocation rates increased from 5.4% in 2021 to 18.4% in 2023. High OOS-use centers increased from 5 (2.2%) between 2021 and June 2022 to 37 (17%) in 2023. Listing at a high-OOS usage center was associated with increased rate of deceased donor transplantation (adjusted hazard ratio [AHR], 3.07; 95% confidence interval [CI], 2.90 to 3.25). Recipients of OOS allocation were more likely to be male (66% versus 59%), White race (38% versus 32%), privately insured (29% versus 24%), and preemptively transplanted (18% versus 10%). Overall graft loss was not significantly different between OOS and standard allocated transplants (AHR, 0.94; 95% CI, 0.85 to 1.05), consistent in paired donor analysis (AHR, 1.10; 95% CI, 0.86 to 1.41). CONCLUSIONS: Short-term kidney graft failure does not differ between OOS and standard allocation. High-OOS kidney centers have higher deceased donor transplant rates. Further investigation is needed to understand demographic differences and factors explaining OOS allocation.
引用
- Huml AM, Augustine JJ, Poggio ED, et al. Outcomes of Deceased Donor Kidney Transplants Allocated Out of Sequence in the United States. Clin J Am Soc Nephrol. 2025. PMID: 41348496. doi:10.2215/CJN.0000000945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。